Challenges of characterizing proarrhythmic risk due to QTc prolongation induced by nonadjuvant anticancer agents. [electronic resource]
- Expert opinion on drug safety May 2008
- 305-18 p. digital
Publication Type: Journal Article; Review
1744-764X
10.1517/14740338.7.3.305 doi
Antineoplastic Agents--adverse effects Drug Approval Drug Labeling Electrocardiography Humans International Cooperation Long QT Syndrome--chemically induced Practice Guidelines as Topic Risk Assessment Torsades de Pointes--chemically induced